Structure Therapeutics Inc. American Depositary Shares (GPCR · NASDAQ)
GPCR · MARKET VIEW
Market view · as of Jul 13, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-0.35
vs $-0.33 est · miss
52-wk position
47.9%
-43.1% vs 52w high · +28.5% 1mo
Price (last ~year)
Clinical-stage biopharmaceutical company Structure Therapeutics, which focuses on oral GLP-1 and amylin therapeutics, currently holds a $3.92 billion market capitalization with $0 in trailing twelve-month revenue. For the quarter ended March 31, 2026, the company reported a net loss of $76.2 million, supported by a cash position of $316.2 million against $5.8 million in total debt. Shares trade at $53.36, reflecting a 28.5% gain over the last month and an RSI of 73.
Valuation
- Market cap
- $3.92B
- P/B
- 2.709
- EV/EBITDA
- -13.46
- Beta
- -1.569
- Analyst target
- $104.59
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -15.0%
- ROA
- -11.6%
Price movement
- Last
- $53.36
- 1-month
- +28.5%
- 3-month
- +0.3%
- RSI (14)
- 73
- vs SMA200
- +6.0%
- 52-wk position
- 47.9% -43.1% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $0 | $-89.6M | $-76.2M | $-74.8M |
| 2025-12-31 | $0 | $24.0M | $33.0M | $33.6M |
| 2025-09-30 | $0 | $-73.8M | $-65.7M | $-65.3M |
| 2025-06-30 | $0 | $-70.5M | $-61.7M | $-61.2M |
Recent news
- Bullish Structure Therapeutics (GPCR) Morgan Stanley 23rd Annual Global Healthcare Conference summary · 2026-07-09
- Bullish (GPCR) as a Liquidity Pulse for Institutional Tactics · 2026-07-07
- Bullish Structure Therapeutics (GPCR) Corporate presentation Summary · 2026-07-06
- Somewhat-Bullish If You Invested $1,000 in Structure Therapeutics Inc ADR (GPCR) · 2026-07-04
- Neutral GPCR - Structure Therapeutics Inc ADR Options · 2026-07-03
- Somewhat-Bullish GPCR Stock News Today | Earnings, Events & Price Alerts · 2026-07-02
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)